DZ3366A1 - Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase - Google Patents
Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthaseInfo
- Publication number
- DZ3366A1 DZ3366A1 DZ013366A DZ013366A DZ3366A1 DZ 3366 A1 DZ3366 A1 DZ 3366A1 DZ 013366 A DZ013366 A DZ 013366A DZ 013366 A DZ013366 A DZ 013366A DZ 3366 A1 DZ3366 A1 DZ 3366A1
- Authority
- DZ
- Algeria
- Prior art keywords
- thiazol
- dihydro
- synthase inhibitors
- ylamine derivatives
- ylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007396A FR2810036B1 (fr) | 2000-06-09 | 2000-06-09 | Derives de 4,5-dihydro-1,3-thiazol-2-ylamine, leur preparation et les compositions phamarceutiques les contenant |
PCT/FR2001/001759 WO2001093867A1 (fr) | 2000-06-09 | 2001-06-07 | Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3366A1 true DZ3366A1 (fr) | 2001-12-13 |
Family
ID=8851133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ013366A DZ3366A1 (fr) | 2000-06-09 | 2001-06-07 | Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1299103B1 (ko) |
JP (1) | JP4171297B2 (ko) |
KR (1) | KR20030017990A (ko) |
CN (1) | CN1441673A (ko) |
AP (1) | AP2002002707A0 (ko) |
AT (1) | ATE305298T1 (ko) |
AU (2) | AU2001266123B2 (ko) |
BR (1) | BR0111543A (ko) |
CA (1) | CA2411572C (ko) |
DE (1) | DE60113686T2 (ko) |
DK (1) | DK1299103T3 (ko) |
DZ (1) | DZ3366A1 (ko) |
EA (1) | EA200300009A1 (ko) |
EC (1) | ECSP024374A (ko) |
ES (1) | ES2246327T3 (ko) |
FR (1) | FR2810036B1 (ko) |
HR (1) | HRP20020971A2 (ko) |
HU (1) | HUP0300996A3 (ko) |
IL (1) | IL153327A0 (ko) |
MA (1) | MA25815A1 (ko) |
MX (1) | MXPA02012072A (ko) |
NO (1) | NO20025885L (ko) |
NZ (1) | NZ522967A (ko) |
OA (1) | OA12285A (ko) |
PL (1) | PL360282A1 (ko) |
WO (1) | WO2001093867A1 (ko) |
ZA (1) | ZA200209770B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088935B2 (en) | 2003-12-23 | 2012-01-03 | Ironwood Pharmaceuticals, Inc. | Compounds and methods for the treatment of asthma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08503940A (ja) * | 1992-11-27 | 1996-04-30 | ザ ウエルカム ファウンデーション リミテッド | 酵素阻害薬 |
KR100342275B1 (ko) * | 1993-10-21 | 2002-12-05 | 지.디. 썰 엘엘씨 | 산화질소신타제저해제로서유용한아미디노유도체 |
WO1996014842A1 (en) * | 1994-11-15 | 1996-05-23 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
-
2000
- 2000-06-09 FR FR0007396A patent/FR2810036B1/fr not_active Expired - Fee Related
-
2001
- 2001-06-07 AU AU2001266123A patent/AU2001266123B2/en not_active Ceased
- 2001-06-07 DE DE60113686T patent/DE60113686T2/de not_active Expired - Lifetime
- 2001-06-07 KR KR1020027016786A patent/KR20030017990A/ko not_active Application Discontinuation
- 2001-06-07 JP JP2002501440A patent/JP4171297B2/ja not_active Expired - Fee Related
- 2001-06-07 AT AT01943579T patent/ATE305298T1/de not_active IP Right Cessation
- 2001-06-07 PL PL36028201A patent/PL360282A1/xx unknown
- 2001-06-07 HU HU0300996A patent/HUP0300996A3/hu unknown
- 2001-06-07 AU AU6612301A patent/AU6612301A/xx active Pending
- 2001-06-07 MX MXPA02012072A patent/MXPA02012072A/es active IP Right Grant
- 2001-06-07 DZ DZ013366A patent/DZ3366A1/xx active
- 2001-06-07 OA OA1200200371A patent/OA12285A/fr unknown
- 2001-06-07 CA CA002411572A patent/CA2411572C/fr not_active Expired - Fee Related
- 2001-06-07 CN CN01812587A patent/CN1441673A/zh active Pending
- 2001-06-07 BR BR0111543-0A patent/BR0111543A/pt not_active Application Discontinuation
- 2001-06-07 NZ NZ522967A patent/NZ522967A/en unknown
- 2001-06-07 DK DK01943579T patent/DK1299103T3/da active
- 2001-06-07 EA EA200300009A patent/EA200300009A1/ru unknown
- 2001-06-07 ES ES01943579T patent/ES2246327T3/es not_active Expired - Lifetime
- 2001-06-07 WO PCT/FR2001/001759 patent/WO2001093867A1/fr active IP Right Grant
- 2001-06-07 EP EP01943579A patent/EP1299103B1/fr not_active Expired - Lifetime
- 2001-06-07 IL IL15332701A patent/IL153327A0/xx unknown
- 2001-06-07 AP APAP/P/2002/002707A patent/AP2002002707A0/en unknown
-
2002
- 2002-12-02 ZA ZA200209770A patent/ZA200209770B/en unknown
- 2002-12-06 NO NO20025885A patent/NO20025885L/no not_active Application Discontinuation
- 2002-12-06 HR HR20020971A patent/HRP20020971A2/xx not_active Application Discontinuation
- 2002-12-09 MA MA26940A patent/MA25815A1/fr unknown
- 2002-12-09 EC EC2002004374A patent/ECSP024374A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27001A1 (fr) | Derives spirotricycliques nouveaux et leur utilisation comme inhibiteurs de phospho-diesterase-7 | |
DZ3186A1 (fr) | Ptéridinones utilisées comme inhibiteurs de kinase. | |
PT1226136E (pt) | Inibidores da tirosina quinase | |
MA26771A1 (fr) | Benzoheterocycles et leur utilisation comme inhibiteurs de mek. | |
MXPA03004794A (es) | Derivados de acido mandelico y su uso como inhibidores de trombina. | |
CY2007002I1 (el) | Ω-καρβοξυαρυλυποκατεστημενες διφαινυλουριες σαν αναστολεις της raf κινασης | |
AR028576A1 (es) | Derivados de b-carbolina utiles como inhibidores de fosfodiesterasa | |
DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
SI1686119T1 (sl) | Derivati pirimidin-5-ona kot inhibitorji ldl-pla2 | |
DZ3439A1 (fr) | Derives de 2-aminocarbonyl-9h-purine | |
MA26976A1 (fr) | Derives du tetrahydropyridine, leur preparation et leur utilisation comme inhibiteur de proliferation de cellules | |
DZ3415A1 (fr) | Guanidinobenzamides comme mc4-r agonistes. | |
PT1194404E (pt) | Inibidores de aspartil-protease | |
FR2806720B1 (fr) | Derives de 2,2,6,6-diethyl-dimethyl-1-alcoxypiperidines et 1-oxydes correspondants | |
MXPA03003314A (es) | Compuestos de c-nitrosoanilina y sus mezclas como inhibidores de polimerizacion. | |
PT1171440E (pt) | 3-ciano-¬1,7|,¬1,5|, e ¬1,8|-naftiridinas substituidas inibidoras de tirosina quinases | |
FR2810318B1 (fr) | Derives de diamano-phenothiazine | |
IL148275A0 (en) | Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors | |
AR028607A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
MA25814A1 (fr) | Derives de 2-aminothiazoline et leur utilisation comme inhibiteurs de no-synthase. | |
DZ3366A1 (fr) | Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase | |
AU2001293869A1 (en) | Butenolide and pentenolide derivatives as kinase inhibitors | |
EE04494B1 (et) | 1-oksa-, asa- ja tianaftaleen-2-oon biseetrid fosfolambaani inhibiitoritena | |
ATE264308T1 (de) | Aminoalkyl-3,4-dihydrochinolin-derivate als no synthase inhibitoren | |
ZA200206528B (en) | Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors. |